• A case of mevalonate kinase deficiency, neonatal Sweet syndrome, and inflammatory bowel disease
• A case of neonatal sweet syndrome associated with mevalonate kinase deficiency
• A novel homozygous variant in PMVK is associated with enhanced IL1β secretion and a hyper-IgD syndrome-like phenotype
• A possibly new autoinflammatory disease due to compound heterozygous phosphomevalonate kinase gene mutation
• AA amyloidosis presenting with acute kidney injury, curable or not?
• Actin Remodeling Defects Leading to Autoinflammation and Immune Dysregulation
• An Atypical Presentation of Mevalonate Kinase Deficiency in Response to Colchicine Treatment
• Analysis of clinical characteristics of 35 inflammasomopathies cases
• Analysis of MVK gene variant in a child with high IgD syndrome caused by mevalonate kinase deficiency
• Autoinflammation-differences between children and adults
• Autoinflammatory Diseases/Periodic Fevers
• Autoinflammatory Recurrent Pericarditis Associated with a New NLRP12 Mutation in a Male Adolescent
• B Cells at the Cross-Roads of Autoimmune Diseases and Auto-Inflammatory Syndromes
• Canakinumab improves patient-reported outcomes in children and adults with autoinflammatory recurrent fever syndromes: results from the CLUSTER trial
• Canakinumab treatment real world evidence in 3 monogenic periodic fever syndromes in 2009-2022: an interim analysis using the French JIR cohort database
• Cardiovascular manifestations of monogenic periodic fever syndromes
• Case Report: Comorbid Hyper-IgD Syndrome and Hidradenitis Suppurativa - A New Syndromic Form of HS? A Report of Two Cases
• Case Report: Mevalonic Aciduria Complicated by Acute Myeloid Leukemia After Hematopoietic Stem Cell Transplantation
• Clinical presentation and genetic variants in patients with autoinflammatory diseases: results from the German GARROD registry
• Comparison of the clinical diagnostic criteria and the results of the next-generation sequence gene panel in patients with monogenic systemic autoinflammatory diseases
• Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency
• Corrigendum to: Haploidentical alpha/beta T-cell and B-cell depleted stem cell transplantation in severe mevalonate kinase deficiency
• Corrigendum to: Haploidentical α/β T-cell and B-cell depleted stem cell transplantation in severe mevalonate kinase deficiency
• Current Evidence on Vaccinations in Pediatric and Adult Patients with Systemic Autoinflammatory Diseases
• Current treatment options for monogenic periodic fever syndromes - the role of interleukin 1 inhibitors
• Cyclic Fevers in Adult Diagnosed As Hyperimmunoglobulin D Syndrome
• Deep intronic variant in MVK as a cause for mevalonic aciduria initially presenting as non-syndromic retinitis pigmentosa
• Detection of a rare variant in PSTPIP1 through three generations in a family with an initial diagnosis of FMF/MKD-overlapping phenotype
• Diagnostic and therapeutic algorithms for monogenic autoinflammatory diseases presenting with recurrent fevers among adults
• Differentiating children with familial Mediterranean fever from other recurrent fever syndromes: The utility of new Eurofever/PRINTO classification criteria
• Disseminated superficial actinic porokeratosis following hydroxyurea treatment: A case report
• Efficacy of Anakinra Treatment in two Moroccan Patients With Mevalonate Kinase Deficiency
• Expanding Contributions of Monogenic Very Early Onset Inflammatory Bowel Disease
• Experience on the long-term use of canakinumab in mevalonate kinase deficiency: A case series
• Fitness to Serve in the Armed Forces and Internal Medicine: A Retrospective Study
• Gene Expression Analysis of Mevalonate Kinase Deficiency Affected Children Identifies Molecular Signatures Related to Hematopoiesis
• Glucose-oxygen deprivation constrains HMGCR function and Rac1 prenylation and activates the NLRP3 inflammasome in human monocytes
• Haploidentical alpha/beta T-cell and B-cell depleted stem cell transplantation in severe mevalonate kinase deficiency
• Haploidentical α/β T-cell and B-cell depleted stem cell transplantation in severe mevalonate kinase deficiency
• Homozygous V377I mutation causing mevalonate kinase
• Hyper-IgD Syndrome: Caused by Deficiency on Ras Prenylation and Trained Immunity?
• Identification of FDA-approved drugs that increase mevalonate kinase in hyper IgD syndrome
• IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives
• Immunodeficiency-Like Phenotype, Recurrent Pulmonary Manifestations, and Persistent Polyarthritis: Mevalonate Kinase Deficiency Successfully Treated With Adalimumab
• Incomplete mitophagy in the mevalonate kinase-deficient Saccharomyces cerevisiae and its relation to the MKD-related autoinflammatory disease in humans
• Increased core body temperature exacerbates defective protein prenylation in mouse models of mevalonate kinase deficiency
• Inflammatory turmoil within: an exploration of autoinflammatory disease genetic underpinnings, clinical presentations, and therapeutic approaches
• Interstitial lung disease in autoinflammatory disease in childhood: A systematic review of the literature
• Ischemic stroke is a potential complication of uncontrolled inflammation in mevalonate kinase deficiency - A case report
• Isolated neurological presentations of mevalonate kinase deficiency
• Joint manifestations revealing inborn metabolic diseases in adults: a narrative review
• Kidney Involvement in Autoinflammatory Diseases
• Lipids in inflammasome activation and autoinflammatory disorders
• Long-term efficacy and safety of canakinumab in patients with mevalonate kinase deficiency: results from the randomised Phase 3 CLUSTER trial
• Long-term efficacy of canakinumab in hyperimmunoglobulin D syndrome
• Long-Term Follow-Up and Optimization of Interleukin-1 Inhibitors in the Management of Monogenic Autoinflammatory Diseases: Real-Life Data from the JIR Cohort
• Long-term safety and effectiveness of canakinumab in patients with monogenic autoinflammatory diseases: results from the interim analysis of the RELIANCE registry
• Making a diagnosis of periodic fever syndrome: Experience from a single tertiary centre
• Mevalonate kinase deficiency
• Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation
• Mevalonate Kinase Deficiency: A Cause of Severe Very-Early-Onset Inflammatory Bowel Disease
• Mevalonate Kinase Deficiency: Diagnostic and Management Challenges
• Mevalonate kinase deficiency/Hyperimmunoglobulin D syndrome (MVK/HIDS) in a Differential Diagnosis of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Familial Mediterranean Fever (FMF): A Case Report
• Mevalonate Kinase-Associated Diseases: Hunting for Phenotype-Genotype Correlation
• Mevalonate kinase-deficient THP-1 cells show a disease-characteristic pro-inflammatory phenotype
• Mevalonic Aciduria Associated With Intrahepatic Bile Duct Paucity
• Mevalonic Aciduria in a Pediatric Patient: A Case Report and Literature Review of Neuroimaging Findings
• Molecular and cellular consequences of mevalonate kinase deficiency
• Neurological manifestations in mevalonate kinase deficiency: A systematic review
• Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency successfully treated with the addition of ustekinumab
• Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on 'Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate kinase deficiency
• Performance of recent PRINTO criteria versus current ILAR criteria for systemic juvenile idiopathic arthritis: A single-centre experience
• Phenotypic diversity, disease progression, and pathogenicity of MVK missense variants in mevalonic aciduria
• Phosphomevalonate Kinase Controls beta-Catenin Signaling via the Metabolite 5-Diphosphomevalonate
• Phosphomevalonate Kinase Controls β-Catenin Signaling via the Metabolite 5-Diphosphomevalonate
• Phosphomevalonate kinase deficiency expands the genetic spectrum of systemic autoinflammatory diseases
• Practical Approach to Diagnosis and Management of IL-1-Mediated Autoinflammatory Diseases (CAPS, TRAPS, MKD, and DIRA)
• Real-Life Indications of Interleukin-1 Blocking Agents in Hereditary Recurrent Fevers: Data From the JIRcohort and a Literature Review
• Real-world safety and effectiveness of canakinumab in patients with tumour necrosis factor receptor-associated periodic syndrome or hyperimmunoglobulinaemia D syndrome: Interim results from post-marketing surveillance in Japan
• Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States
• Recent Insights in Pyrin Inflammasome Activation: Identifying Potential Novel Therapeutic Approaches in Pyrin-Associated Autoinflammatory Syndromes
• Recurrent macrophage activation syndrome due to hyperimmunoglobulin D syndrome: a case-based review
• Reply to 'Paradoxical hidradenitis suppurativa induced by adalimumab biosimilar successfully treated with guselkumab in a patient with psoriasis. Comment on "Paradoxical hidradenitis suppurativa due to anti-interleukin-1 agents for mevalonate ki
• Spectrum of auto-inflammatory diseases in Morocco: a monocentric experience
• Spectrum of Systemic Auto-Inflammatory Diseases in India: A Multi-Centric Experience
• Successful treatment of refractory mevalonate kinase deficiency with combination therapy targeting TNFalpha and IL1beta
• Systemic autoinflammatory disease, IgA glomerulonephritis and renal cortical necrosis: coincidence or causation?
• The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated period
• The Added Value of a Multidisciplinary Clinic for Systemic Autoinflammatory Diseases
• The assessment of autoinflammatory disease classification criteria (Eurofever/PRINTO) in a real-life cohort
• The Clinical Chameleon of Autoinflammatory Diseases in Children
• The efficacy and safety of allogeneic stem cell transplantation in Mevalonate Kinase Deficiency
• Tocilizumab for treating mevalonate kinase deficiency and TNF receptor-associated periodic syndrome: a case series and literature review
• Twists and turns of the genetic story of mevalonate kinase-associated diseases: A review
• Two Siblings With Recurrent Fevers: The Path to Mevalonate Kinase Deficiency Diagnosis
• Use of the Auto-inflammatory Disease Activity Index to monitor disease activity in patients with colchicine-resistant Familial Mediterranean Fever, Mevalonate Kinase Deficiency, and TRAPS treated with canakinumab
• Utility of a targeted next-generation sequencing-based genetic screening panel in patients with periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome
• Uveitis, glaucoma, and cataract with mevalonate kinase deficiency
• Vasculitis in a patient with mevalonate kinase deficiency (MKD): a case report
• What is confirmed in the treatment of autoinflammatory fever diseases?